The value of software that provides clinically relevant information on drug interactions

Published: 20 July 2015
Author(s): Stefania Antoniazzi, Maria Teresa Chiarelli, Alessandro Nobili, Luca Pasina, Francesca Venturini
Section: Letter to the Editor

Potential drug–drug interactions (pDDIs) are critical issues in the management of the elderly. The development of multiple diseases with increasing age leads to therapies based upon many concomitant drugs, a risk factor for severe pDDIs [1]. Pharmacological interactions may affect patient health by leading to adverse drug reactions and more hospitalisations [2–4], so that they also represent a cost for the healthcare systems [5]. In order to minimise pDDIs and assist clinicians with information readily available at the time of prescription, the computerised prescription support system (CPSS) INTERCheck® was developed by the IRCCS Istituto di Ricerche Mario Negri of Milan.